- Info
- Significant Ownership
- Insider Ownership
Significant Ownership of Steven Michael Oliveira
- Signature - Title
- /s/ Oliveira Steven Michael - Individual
- Location
- New City, NY
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Steven Michael Oliveira.
Follow Filing Activity
Follow Steven Michael Oliveira and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Steven Michael Oliveira
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ATHA | Athira Pharma, Inc. | Common Stock | 4.1% | $69,324 | -$788,375 | 161,218 | -92% | Oliveira Steven Michael | 01 Oct 2025 |
| FBRX | Forte Biosciences, Inc. | Common Stock, $0.001 par value | 2.4% | $6,797,265 | -$2,993,786 | 300,100 | -31% | Oliveira Steven Michael | 08 Jan 2026 |
Schedules 13D/G Reported by Steven Michael Oliveira:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.